Ambit Biosciences
Biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications
Portfolio
Applied Genetic Technologies Corp.
Gene therapy company focused on the research and development of novel therapeutics for patients with unmet medical needs utilizing AGTC's proprietary, non-pathogenic adeno-associated virus (AAV) delivery system
BrainCells Inc.
Drug discovery and development company that focuses on neurogenesis using its proprietary human neural stem cell platform technology to treat various CNS diseases
Catabasis
Biopharmaceutical company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases
Corridor Pharmaceuticals
Biopharmaceutical company that focuses on arginase inhibition to promote endothelial function
Elusys Therapeutics
Biopharmaceutical company focused on the development of antibody therapeutics for the treatment of life-threatening diseases
Hydra Biosciences
Biopharmaceutical company that develops drugs to treat pain, inflammation, cardiovascular, and other diseases using its expertise in novel ion channels
Inotek Pharmaceuticals
Biopharmaceutical firm focused on the development of innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma
Ligocyte Pharmaceuticals
Biotechnology company focused on developing novel vaccines for gastrointestinal and respiratory indications using its virus-like particles technology
NeuProtect
NeuProtect Pty Ltd is a life sciences start-up company based in Melbourne, Australia. NeuProtect is developing proprietary cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke
NKT Therapeutics
Biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells
Rib-X Pharmaceuticals
Small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics
Synovex
Biotechnology company developing novel antibody therapeutic for rheumatoid arthritis and other indications
VaxInnate
Biotechnology company developing novel, proprietary vaccines for infectious diseases
VentiRx Pharmaceuticals
Biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer, respiratory, and autoimmune diseases
VLST
Biotechnology company dedicated to the streamlined discovery and development of novel therapeutics for the treatment of autoimmune and inflammatory disorders
Xencor
Biotechnology company that focuses on antibody engineering to significantly improve antibody half-life, immune-regulatory function and potency
The links in this section will take you to web sites maintained by third parties. All content on the third party sites is the responsibility of the owners of the sites, including protection of your privacy, which is governed by the privacy policy of those sites. We encourage you to read the Privacy Policy of every web site you visit.